36 results
Page 2 of 2
424B3
c2a0ycp3wo
13 Aug 21
Prospectus supplement
5:25pm
8-K
EX-99.1
szwrd42fe3dx0j2
1 Jun 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
4:32pm
425
EX-99.1
rw254ai1
1 Jun 21
Business combination disclosure
4:30pm
S-4/A
EX-10.8
xdjd903or
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.13
l4z5 ey86l2x8
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.7
gvthsg6s
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.12
dvy4pd6
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
8-K
EX-99.1
y4wmlrhqghl3
28 Apr 21
POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility
5:13pm
425
EX-99.1
5xsp54y
28 Apr 21
Business combination disclosure
5:11pm
S-4
EX-10.8
iccqqdwg0tcrlco5opnz
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.12
12h78nwye05z9cae4
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.13
ic34p
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.7
oopa6w8y
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
425
EX-99.1
0zx gfnkxzi1k
15 Mar 21
Business combination disclosure
8:20am
8-K
EX-99.1
riphykuflt148rb8
15 Mar 21
Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I
8:19am